• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于抗原呈递细胞靶向抗原递送的甘露糖修饰羧化凝胶多糖包被脂质体的研制

Development of Mannose-Modified Carboxylated Curdlan-Coated Liposomes for Antigen Presenting Cell Targeted Antigen Delivery.

作者信息

Yuba Eiji, Fukaya Yoshiki, Yanagihara Shin, Kasho Nozomi, Harada Atsushi

机构信息

Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 5998531, Japan.

出版信息

Pharmaceutics. 2020 Aug 11;12(8):754. doi: 10.3390/pharmaceutics12080754.

DOI:10.3390/pharmaceutics12080754
PMID:32796567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7465930/
Abstract

Specific delivery to antigen presenting cells (APC) and precise control of the intracellular fate of antigens are crucial to induce cellular immunity that directly and specifically attacks cancer cells. We previously achieved cytoplasmic delivery of antigen and activation of APC using carboxylated curdlan-modified liposomes, which led to the induction of cellular immunity in vivo. APCs express mannose receptors on their surface to recognize pathogen specifically and promote cross-presentation of antigen. In this study, mannose-residue was additionally introduced to carboxylated curdlan as a targeting moiety to APC for further improvement of polysaccharide-based antigen carriers. Mannose-modified curdlan derivatives were synthesized by the condensation between amino group-introduced mannose and carboxy group in pH-sensitive curdlan. Mannose residue-introduced carboxylated curdlan-modified liposomes showed higher pH-sensitivity than that of liposomes modified with conventional carboxylated curdlan. The introduction of mannose-residue to the liposomes induced aggregation in the presence of Concanavalin A, indicating that mannose residues were presented onto liposome surface. Mannose residue-introduced carboxylated curdlan-modified liposomes exhibited high and selective cellular association to APC. Furthermore, mannose residue-introduced carboxylated curdlan-modified liposomes promoted cross-presentation of antigen and induced strong antitumor effects on tumor-bearing mice. Therefore, these liposomes are promising as APC-specific antigen delivery systems for the induction of antigen-specific cellular immunity.

摘要

特异性递送至抗原呈递细胞(APC)以及精确控制抗原在细胞内的命运对于诱导直接且特异性攻击癌细胞的细胞免疫至关重要。我们之前使用羧化凝胶多糖修饰的脂质体实现了抗原的胞质递送和APC的激活,这在体内诱导了细胞免疫。APC在其表面表达甘露糖受体以特异性识别病原体并促进抗原的交叉呈递。在本研究中,将甘露糖残基作为靶向APC的部分额外引入羧化凝胶多糖中,以进一步改进基于多糖的抗原载体。通过在pH敏感的凝胶多糖中引入氨基的甘露糖与羧基之间的缩合反应合成了甘露糖修饰的凝胶多糖衍生物。引入甘露糖残基的羧化凝胶多糖修饰的脂质体比用传统羧化凝胶多糖修饰的脂质体表现出更高的pH敏感性。在存在伴刀豆球蛋白A的情况下,向脂质体中引入甘露糖残基会诱导聚集,表明甘露糖残基呈现在脂质体表面。引入甘露糖残基的羧化凝胶多糖修饰的脂质体对APC表现出高度且选择性的细胞结合。此外,引入甘露糖残基的羧化凝胶多糖修饰的脂质体促进了抗原的交叉呈递,并对荷瘤小鼠诱导了强烈的抗肿瘤作用。因此,这些脂质体作为用于诱导抗原特异性细胞免疫的APC特异性抗原递送系统具有广阔前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/6490ecc118f7/pharmaceutics-12-00754-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/0ccbecb87896/pharmaceutics-12-00754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/466483f7dc52/pharmaceutics-12-00754-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/3a70f218f507/pharmaceutics-12-00754-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/ab3c35bdd2e6/pharmaceutics-12-00754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/90aaf6271b10/pharmaceutics-12-00754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/d7ab69c3adb3/pharmaceutics-12-00754-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/6490ecc118f7/pharmaceutics-12-00754-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/0ccbecb87896/pharmaceutics-12-00754-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/466483f7dc52/pharmaceutics-12-00754-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/3a70f218f507/pharmaceutics-12-00754-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/ab3c35bdd2e6/pharmaceutics-12-00754-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/90aaf6271b10/pharmaceutics-12-00754-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/d7ab69c3adb3/pharmaceutics-12-00754-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/543b/7465930/6490ecc118f7/pharmaceutics-12-00754-g006.jpg

相似文献

1
Development of Mannose-Modified Carboxylated Curdlan-Coated Liposomes for Antigen Presenting Cell Targeted Antigen Delivery.用于抗原呈递细胞靶向抗原递送的甘露糖修饰羧化凝胶多糖包被脂质体的研制
Pharmaceutics. 2020 Aug 11;12(8):754. doi: 10.3390/pharmaceutics12080754.
2
Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity.基于生物活性多糖的 pH 敏感聚合物用于细胞质内递抗原和激活抗原特异性免疫。
Biomaterials. 2017 Mar;120:32-45. doi: 10.1016/j.biomaterials.2016.12.021. Epub 2016 Dec 22.
3
Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity.制备糖肽修饰的 pH 敏感脂质体以促进抗原交叉呈递和诱导抗原特异性细胞免疫。
Biomater Sci. 2024 Mar 12;12(6):1490-1501. doi: 10.1039/d3bm01746j.
4
pH-Sensitive branched β-glucan-modified liposomes for activation of antigen presenting cells and induction of antitumor immunity.pH 敏感的分支β-葡聚糖修饰的脂质体,用于激活抗原呈递细胞和诱导抗肿瘤免疫。
J Mater Chem B. 2021 Sep 29;9(37):7713-7724. doi: 10.1039/d1tb00786f.
5
Chondroitin Sulfate-Based pH-Sensitive Polymer-Modified Liposomes for Intracellular Antigen Delivery and Induction of Cancer Immunity.基于硫酸软骨素的 pH 敏感聚合物修饰的脂质体用于细胞内抗原递呈和诱导癌症免疫。
Bioconjug Chem. 2019 May 15;30(5):1518-1529. doi: 10.1021/acs.bioconjchem.9b00221. Epub 2019 Apr 11.
6
Development of pH-sensitive Dextran Derivatives with Strong Adjuvant Function and Their Application to Antigen Delivery.具有强佐剂功能的pH敏感型葡聚糖衍生物的研制及其在抗原递送中的应用
Membranes (Basel). 2017 Aug 4;7(3):41. doi: 10.3390/membranes7030041.
7
Development of pH-Responsive Hyaluronic Acid-Based Antigen Carriers for Induction of Antigen-Specific Cellular Immune Responses.用于诱导抗原特异性细胞免疫反应的pH响应性透明质酸基抗原载体的研发
ACS Biomater Sci Eng. 2019 Nov 11;5(11):5790-5797. doi: 10.1021/acsbiomaterials.9b01278. Epub 2019 Oct 25.
8
Carboxylated polyamidoamine dendron-bearing lipid-based assemblies for precise control of intracellular fate of cargo and induction of antigen-specific immune responses.带有羧化聚酰胺胺树枝状分子的脂质基组装体,用于精确控制货物的细胞内命运并诱导抗原特异性免疫反应。
Biomater Sci. 2021 Apr 21;9(8):3076-3089. doi: 10.1039/d0bm01813a. Epub 2021 Mar 8.
9
Liposome-based immunity-inducing systems for cancer immunotherapy.基于脂质体的癌症免疫治疗诱导免疫体系。
Mol Immunol. 2018 Jun;98:8-12. doi: 10.1016/j.molimm.2017.11.001. Epub 2017 Nov 8.
10
pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.基于 pH 敏感聚合物修饰的脂质体免疫诱导系统:阳离子脂质体和 CpG-DNA 包封的影响。
Biomaterials. 2017 Oct;141:272-283. doi: 10.1016/j.biomaterials.2017.07.001. Epub 2017 Jul 3.

引用本文的文献

1
Targeted Drug Delivery to the Spleen and Its Implications for the Prevention and Treatment of Cancer.靶向药物输送至脾脏及其对癌症预防和治疗的意义。
Pharmaceutics. 2025 May 15;17(5):651. doi: 10.3390/pharmaceutics17050651.
2
Nanomaterial-Driven Precision Immunomodulation: A New Paradigm in Therapeutic Interventions.纳米材料驱动的精准免疫调节:治疗干预的新范式
Cancers (Basel). 2024 May 27;16(11):2030. doi: 10.3390/cancers16112030.
3
Mannose Ligands for Mannose Receptor Targeting.甘露糖配体用于甘露糖受体靶向。

本文引用的文献

1
Enhanced MHC-I antigen presentation from the delivery of ovalbumin by light-facilitated biodegradable poly(ester amide)s nanoparticles.通过光促进的可生物降解聚(酯酰胺)纳米颗粒递送卵清蛋白增强MHC-I抗原呈递。
J Mater Chem B. 2018 Apr 7;6(13):1930-1942. doi: 10.1039/c7tb03233a. Epub 2018 Mar 14.
2
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.抗肿瘤治疗中针对 CD47/SIRPα 轴的研究进展。
Front Immunol. 2020 Jan 28;11:18. doi: 10.3389/fimmu.2020.00018. eCollection 2020.
3
Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications.
Int J Mol Sci. 2024 Jan 23;25(3):1370. doi: 10.3390/ijms25031370.
4
Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.探索糖基纳米疫苗在开发交叉呈递介导的抗肿瘤免疫疗法方面的前景。
Vaccines (Basel). 2022 Nov 30;10(12):2049. doi: 10.3390/vaccines10122049.
5
Synthesis of Small Peptide Nanogels Using Radiation Crosslinking as a Platform for Nano-Imaging Agents for Pancreatic Cancer Diagnosis.利用辐射交联合成小肽纳米凝胶作为胰腺癌诊断纳米成像剂的平台
Pharmaceutics. 2022 Nov 7;14(11):2400. doi: 10.3390/pharmaceutics14112400.
6
A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine.一种脾靶向多功能抗原递送载体:包裹在融合红细胞脂质体中的诱导多能干细胞作为肿瘤纳米疫苗。
Sci Adv. 2021 Aug 25;7(35). doi: 10.1126/sciadv.abi6326. Print 2021 Aug.
通过对刺激响应性材料的修饰来开发功能性脂质体及其在生物医学中的应用。
J Mater Chem B. 2020 Feb 14;8(6):1093-1107. doi: 10.1039/c9tb02470k. Epub 2020 Jan 21.
4
The Role of Nanovaccine in Cross-Presentation of Antigen-Presenting Cells for the Activation of CD8 T Cell Responses.纳米疫苗在抗原呈递细胞交叉呈递以激活CD8 T细胞应答中的作用
Pharmaceutics. 2019 Nov 15;11(11):612. doi: 10.3390/pharmaceutics11110612.
5
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling.治疗性 PD-L1 抗体比 PD-1 抗体更能有效阻断 PD-1/PD-L1 信号通路。
Sci Rep. 2019 Aug 7;9(1):11472. doi: 10.1038/s41598-019-47910-1.
6
Regulation of Antigen Export to the Cytosol During Cross-Presentation.抗原向胞质溶胶中的交叉呈递的调节。
Front Immunol. 2019 Jan 28;10:41. doi: 10.3389/fimmu.2019.00041. eCollection 2019.
7
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?佐剂增强树突状细胞的交叉呈递:更有效的疫苗的关键?
Front Immunol. 2018 Dec 13;9:2874. doi: 10.3389/fimmu.2018.02874. eCollection 2018.
8
Immune checkpoint inhibitors: recent progress and potential biomarkers.免疫检查点抑制剂:最新进展与潜在生物标志物。
Exp Mol Med. 2018 Dec 13;50(12):1-11. doi: 10.1038/s12276-018-0191-1.
9
Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy.级联胞质溶胶递送双敏胶束定制疫苗增强癌症免疫治疗。
ACS Appl Mater Interfaces. 2018 Nov 7;10(44):37797-37811. doi: 10.1021/acsami.8b09946. Epub 2018 Oct 25.
10
Current Concepts of Antigen Cross-Presentation.抗原交叉呈递的当前概念
Front Immunol. 2018 Jul 16;9:1643. doi: 10.3389/fimmu.2018.01643. eCollection 2018.